Some afternoon reading
http://www.expresshealthcare.in/201106/labwatch02.shtml
"Another factor that has driven the growth of immunoassay systems market is the ongoing technology innovations. New technologies for immunoassays are addressing key un-met needs in accuracy, cost, sensitivity and diagnostic speed".
"Key unmet market needs have also encouraged diagnostic companies like Abbott, Siemens, Roche, Biorad, Beckman Coulter, bioM?rieux etc., to develop novel assays, and differentiate themselves from others in order to stay ahead of the competition in the market".
Some afternoon reading...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1838 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 2160397 | 2 |
View Market Depth
| Last trade - 16.12pm 11/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |
Day chart unavailable